Key terms
About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZN news
Today
7:31am ET
AstraZeneca’s Calquence Shows Promise in Lymphoma Trial
Today
2:17am ET
AstraZeneca: Strong Q1 Earnings and Promising Pipeline Reinforce Buy Rating
Yesterday
1:15pm ET
AstraZeneca put volume heavy and directionally bearish
Yesterday
12:02pm ET
AstraZeneca Shares Voting Rights Update
Apr 30
10:13am ET
FTC expands patent listing challenges for drugs
Apr 30
2:21am ET
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Accolade (ACCD) and Morphic Holding (MORF)
Apr 29
8:59am ET
AIM ImmunoTech announces evaluation of first dose level in Phase 1b/2 study
Apr 29
7:09am ET
AstraZeneca and Daiichi Sankyo’s ENHERTU improves PFS in HER2-low
Apr 29
6:31am ET
AstraZeneca reports results from DESTINY-Breast06 Phase 3 trial
Apr 29
6:19am ET
AstraZeneca reports Truqap plus Faslodex recommended for EU approval by CHMP
Apr 26
11:59am ET
AstraZeneca price target raised to 10,500 GBp from 9,900 GBp at UBS
Apr 26
11:37am ET
AstraZeneca price target raised to 13,500 GBp from 13,000 GBp at Barclays
Apr 26
7:20am ET
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and BioMarin Pharmaceutical (BMRN)
Apr 26
5:27am ET
3 Best Healthcare Stocks to Buy in April 2024, According to Analysts
Apr 25
7:27am ET
AstraZeneca’s Q1 2024: Revenue and Dividend Leap
Apr 25
5:52am ET
AstraZeneca backs FY24 core EPS view up low double-digit to low teens percentage
Apr 25
5:49am ET
AstraZeneca reports Q1 core EPS $2.06, consensus $1.22
Apr 25
5:38am ET
AZN Earnings: AstraZeneca Soars on Impressive Q1 Results
Apr 23
11:16am ET
AstraZeneca put volume heavy and directionally bearish
Apr 23
6:30am ET
AstraZeneca reports Voydeya approved in EU as PNH add-on treatment
Apr 19
6:21pm ET
VGK vs. EZU: Which Is the Better European Stock ETF?
Apr 18
9:41am ET
Unusually active option classes on open April 18th
Apr 16
12:49pm ET
AstraZeneca upgraded to Hold from Sell at Deutsche Bank (earlier)
Apr 16
7:12am ET
AstraZeneca: Imfinzi + chemo doubled OS at three years for patients with BTC
Apr 16
6:20am ET
AstraZeneca reports updated exploratory results from TOPAZ-1 Phase 3 trial
Apr 11
2:27pm ET
AstraZeneca’s AGM: Resolutions Passed with Support
Apr 11
7:05am ET
AstraZeneca announces FDA approval for Fasenra
Apr 11
6:14am ET
AstraZeneca increases 2024 dividend by 7% to $3.10 per share
Apr 09
9:00pm ET
ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy?
Apr 08
8:41am ET
Nuvectis says NXP900 demonstrates robust activity in NSCLC
Apr 08
6:58am ET
AstraZeneca’s Enhertu Wins US Approval for Tumours
No recent press releases are available for AZN
AZN Financials
Key terms
Ad Feedback
AZN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range